🔗 Permalink

Inventor profile of:

Nicolas SERGEANT

City:

Ronchin

Country:

France

Published Applications:

Last publication date:

2021-01-28

Top Assignees for applications by Nicolas SERGEANT

The entities that hold a legal rights for patent applications filed by inventor SERGEANT Nicolas:

Alzprotect 4 Loos, France
UNIVERSITE DE LILLE 2 DROIT ET SANTE 2 Lille, France
INSERM INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) 2 Paris, France
Institut National De La Sante Et De La Recherche Medicale (INSERM) 2 Paris, France
Institut National de la Sante et de la Recherche Medicale 2 Paris, France
INNOGENETICS NV 1 Gent-Zwijnaarde, Belgium
UNIVERSITE DU DROIT ET DE LA SANTE- LILLE II 1 Lille, France
UNIVERSITE DU DROIT ET DE LA SANTA-LILLE II 1 Lille, France
Universite de Lille 2 Droit et Saute 1 Lille, France
Inserm (Institut National De La Saute et de la Recherche Medicale 1 Paris, France
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE 1 PARIS, France
INSERM (Institut National De La Sante Et De La Recherche) 1 Paris, France
SANOFI 1 Paris, France
SANOFI-AVENTIS 1 Paris, France
ASSOCIATION INSTITUT DE MYOLOGIE 1 Paris, France
Alzproject 1 Loos, France

Recent patent applications by SERGEANT Nicolas

Nicolas SERGEANT from Ronchin, FR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2021-01-28

US20210024597A1

Chemistry; metallurgy

TREATMENT OF MYOTONIC DYSTROPHY

#2 | 2019-12-19

US20190381036A1

Human necessities

Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, preparation thereof and use of the same

#3 | 2017-06-01

US20170151235A1

Human necessities

Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, preparation thereof and use of the same

#4 | 2017-02-09

US20170035841A1

Human necessities

Treatment of myotonic dystrophy

#5 | 2016-06-02

US20160152610A1

Chemistry; metallurgy

Carboline compounds usable in the treatment of neurodegenerative diseases

#6 | 2016-04-21

US20160108003A1

Chemistry; metallurgy

Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, preparation thereof and use of the same

#7 | 2011-03-10

US20110059092A1

Chemistry; metallurgy

Antibodies specific of the β-amyloid peptides and their uses as diagnostic agents or drugs

#8 | 2009-06-11

US20090149464A1

Human necessities

Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases

#9 | 2008-12-04

US20080299111A1

Human necessities

Prevention, treatment and diagnosis of diseases associated with beta-amyloid formation and/or aggregation

#10 | 2007-02-01

US20070026527A1

Physics

Means for detecting pathological transformation of the APP protein and their uses

#11 | 2006-07-27

US20060166283A1

Chemistry; metallurgy

Means for detecting neurodegenerative processes and applications of same

#12 | 2005-08-11

US20050175626A1

Human necessities

Prevention, treatment and diagnosis of diseases associated with beta-amyloid formation and/or aggregation

InventorID:

1504504 ⎘